Stocktoria
Nuwellis, Inc. NUWE
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2012-02-16
Nuwellis, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $8.3M | $8.7M | $8.9M | $8.5M | $7.9M |
| Gross profit | $5.1M | $5.7M | $5.0M | $4.8M | $4.5M |
| R&D expense | $2.7M | $3.2M | $5.4M | $4.3M | $5.0M |
| SG&A expense | $13.5M | $13.5M | $17.2M | $17.6M | $19.0M |
| Operating income | -$11.1M | -$11.0M | -$17.6M | -$17.2M | -$19.5M |
| Income tax | $5,000 | $5,000 | $8,000 | $9,000 | $9,000 |
| Net income | -$17.5M | -$11.2M | -$20.2M | -$14.5M | -$19.6M |
| EPS (diluted) | $-25.39 | $-353.30 | $-360.06 | $-83.55 | $-285.36 |
| Operating cash flow | -$10.8M | -$9.6M | -$17.9M | -$15.1M | -$17.8M |
| Free cash flow | -$10.9M | -$9.7M | -$18.1M | -$15.3M | -$18.1M |
| Cash & equivalents | $1.1M | $5.1M | $3.8M | $17.7M | $8.7M |
| Inventory | $1.9M | $1.7M | $2.0M | $2.7M | $2.8M |
| Total assets | $6.1M | $9.9M | $9.8M | $24.7M | $30.4M |
| Total liabilities | $3.5M | $3.3M | $6.6M | $12.3M | $4.5M |
| Shareholders' equity | $2.6M | $6.5M | $3.0M | $12.4M | $25.9M |
Source: SEC EDGAR filings · CIK 0001506492 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.